Large cap solutions
We partner with founder- and family-led healthcare companies that are already leaders in their niches, unlocking their next phase of global growth. Our typical partners demonstrate:
Established scale
Revenues of $500M–3B+ and
EBITDA of $200M–1B+
Strong momentum
Organic growth of 15–40%+ per year
Ownership alignment
Founder, family, or management-owned businesses seeking a long-term partner
With more than 175 years of healthcare heritage and a powerful global operator network, we help companies with liquidity and wealth diversification, buyouts of early investors, solving succession challenges, professionalising functions, growth capital, international expansion, pursuing M&A, and preparing for IPOs or strategic sales.
Our focus areas include:
Digitisation of pharma, medtech, diagnostics, care delivery, and payor systems
High-tech leaders in the pharma supply chain
Tools: bioprocessing, diagnostics, research
High-growth medtech niches
We do not invest in biotech, pharma (including generics and specialty pharma), classical payors, or traditional healthcare services.
